Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention1: Group II (Goal directed therapy group) : fluid therapy will be guided by dynamic parameters i.e. maintaining pulse pressure variation (PPV) less than 10%.: Group II (Goal directed thera
Sponsors
Department of OncoAnaesthesia and Palliative Medicine
Eligibility
Inclusion criteria
Inclusion criteria: Laboratory confirmed cases of COVID-19 with severe hypoxemia, requiring invasive mechanical ventilation
Exclusion criteria
Exclusion criteria: a) age b) k/c/o CAD/ cardiac rhythm disorder c) BMI > 40 kg/m2 d) pregnant patients e) patients with coagulopathy/ bleeding disorder f) patients with motor/ neuromuscular disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the effect of two strategies for fluid therapy (goal directed therapy vs standard care) on tissue perfusion as measured by serum lactate in mechanically ventilated COVID-19 patients Timepoint: 48 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| a) haemodynamic parameters b) renal functions as indicated by urine output and serum creatinine.Timepoint: at 48 hours | — |
Countries
India
Contacts
Public ContactDr Sushma Bhatnagar
All India Institute of Medical Sciences, Ansari Nagar, New Delhi
Outcome results
None listed